Research map: Unmet needs in autoimmune liver disease: epidemiology and clinical outcomes from a Southeast Asian cohort

Back to the article

Papers in this map

  1. Primary biliary cirrhosis # † · Keith D. Lindor · 2009 · 1115 citations · Cited by this paper
  2. Biochemical Response in Asian Primary Biliary Cholangitis: A Strong Signal, but Not the Whole Story · Jeanette Pei Xuan Ng · 2026 · Cites this paper
  3. Evaluating the feasibility of Steady Feet: a community-based group exercise programme for older adults at risk of falls · 2026 · Related
  4. AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma · Christopher L. Bowlus · 2022 · 423 citations · Cited by this paper
  5. Outcomes of free flaps in patients with diabetes mellitus and open lower limb fractures: a retrospective cohort study · 2026 · Related
  6. EASL Clinical Practice Guidelines on sclerosing cholangitis · Olivier Chazouillères · 2022 · 411 citations · Cited by this paper
  7. Approach to facial pain · 2026 · Related
  8. Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group · Simon Pape · 2022 · 181 citations · Cited by this paper
  9. Metabolic dysfunction-associated steatotic liver disease in Asia: implications on management · 2026 · Related
  10. Global incidence and prevalence of autoimmune hepatitis, 1970–2022: a systematic review and meta-analysis · Jong Woo Hahn · 2023 · 112 citations · Cited by this paper
  11. Our power, our planet: medicine and environmental stewardship · 2026 · Related
  12. Clinical profile of primary sclerosing cholangitis in Singapore · Tiing Leong Ang · 2002 · 96 citations · Cited by this paper
  13. Foreword · 2026 · Related
  14. Approach to the patient with acute severe autoimmune hepatitis · Mussarat Nazia Rahim · 2020 · 91 citations · Cited by this paper
  15. Evidence-to-Recommendation Framework for 2026 ACE Clinical Guideline on allergic rhinitis — diagnosis and management · 2026 · Related
  16. Predniso(lo)ne Dosage and Chance of Remission in Patients With Autoimmune Hepatitis · Simon Pape · 2019 · 90 citations · Cited by this paper
  17. Positioning of advanced therapies in patients with moderate-to-severe Crohn’s disease · 2026 · Related
  18. An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis · Romée J.A.L.M. Snijders · 2023 · 83 citations · Cited by this paper
  19. Efficacy of intravenous reperfusion treatment in acute ischaemic stroke with age-dependent variables: a 10-year single-centre study · 2026 · Related
  20. Diagnosis and Management of Cholestatic Liver Disease · E. Jenny Heathcote · 2007 · 78 citations · Cited by this paper
  21. Diagnosis and analysis of plasma phosphorylated tau 217 in a memory clinic cohort: limitations of Generative Pre-trained Transformer-5 · 2026 · Related
  22. Autoimmune hepatitis in Singapore: A rare syndrome affecting middle‐aged women · Yin Mei Lee · 2001 · 74 citations · Cited by this paper
  23. Role of Glucocorticoids in Metabolic Dysfunction-Associated Steatotic Liver Disease · Stergios A. Pοlyzos · 2024 · 60 citations · Cited by this paper
  24. Extrahepatic autoimmunity in autoimmune liver disease · Annarosa Floreani · 2018 · 58 citations · Cited by this paper
  25. Primary biliary cirrhosis in Singapore: Evaluation of demography, prognostic factors and natural course in a multi‐ethnic population · Reuben K. M. Wong · 2007 · 27 citations · Cited by this paper
  26. Treatment in primary biliary cholangitis: Beyond ursodeoxycholic acid · Maria C. van Hooff · 2024 · 26 citations · Cited by this paper
  27. Autoimmune hepatitis: Diagnostic criteria and serological testing · Diego Vergani · 2014 · 16 citations · Cited by this paper
  28. TPMT and NUDT15 testing for thiopurine therapy: A major tertiary hospital experience and lessons learned · Liuh Ling Goh · 2022 · 16 citations · Cited by this paper
  29. Impact of metabolic risk factors on hepatic and cardiac outcomes in patients with alcohol- and non-alcohol-related fatty liver disease · Ji Hyae Lim · 2023 · 8 citations · Cited by this paper
  30. The impact of deep response to ursodeoxycholic acid in primary biliary cholangitis – should it be the new clinical standard? · Adrielly Martins · 2025 · 1 citation · Cited by this paper

Source: OpenAlex (CC0)